OBI Pharma announces COVID-19 vaccine clinical trials to start in 2022
Taipei, Feb. 8 (CNA) Taiwan-based biotech firm OBI Pharma Inc. announced Tuesday that the COVID-19 vaccine it developed called BCVax will enter phase 1 & 2 clinical trials in the second half of this year.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Taiwan shares close up 0.2%12/11/2023 01:53 PM
Parties draw lots for placement on Taiwan's presidential ballot12/11/2023 12:32 PM
Mercury forecast to soar past 30 degrees Monday in western Taiwan12/11/2023 11:49 AM
U.S. dollar up in Taipei trading12/11/2023 10:24 AM
Taiwan headline news12/11/2023 10:22 AM